1. Home
  2. PPBT vs EVAX Comparison

PPBT vs EVAX Comparison

Compare PPBT & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PPBT
  • EVAX
  • Stock Information
  • Founded
  • PPBT 2010
  • EVAX 2008
  • Country
  • PPBT Israel
  • EVAX Denmark
  • Employees
  • PPBT N/A
  • EVAX N/A
  • Industry
  • PPBT Biotechnology: Pharmaceutical Preparations
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PPBT Health Care
  • EVAX Health Care
  • Exchange
  • PPBT Nasdaq
  • EVAX Nasdaq
  • Market Cap
  • PPBT 8.7M
  • EVAX 8.7M
  • IPO Year
  • PPBT N/A
  • EVAX 2021
  • Fundamental
  • Price
  • PPBT $3.11
  • EVAX $2.34
  • Analyst Decision
  • PPBT Strong Buy
  • EVAX Strong Buy
  • Analyst Count
  • PPBT 2
  • EVAX 3
  • Target Price
  • PPBT $126.50
  • EVAX $33.33
  • AVG Volume (30 Days)
  • PPBT 38.0K
  • EVAX 6.9M
  • Earning Date
  • PPBT 03-04-2025
  • EVAX 03-26-2025
  • Dividend Yield
  • PPBT N/A
  • EVAX N/A
  • EPS Growth
  • PPBT N/A
  • EVAX N/A
  • EPS
  • PPBT N/A
  • EVAX N/A
  • Revenue
  • PPBT N/A
  • EVAX $3,295,000.00
  • Revenue This Year
  • PPBT N/A
  • EVAX $4,845.21
  • Revenue Next Year
  • PPBT N/A
  • EVAX $30.30
  • P/E Ratio
  • PPBT N/A
  • EVAX N/A
  • Revenue Growth
  • PPBT N/A
  • EVAX N/A
  • 52 Week Low
  • PPBT $2.00
  • EVAX $2.22
  • 52 Week High
  • PPBT $20.60
  • EVAX $23.70
  • Technical
  • Relative Strength Index (RSI)
  • PPBT 39.58
  • EVAX 38.89
  • Support Level
  • PPBT $2.83
  • EVAX $2.22
  • Resistance Level
  • PPBT $3.37
  • EVAX $4.05
  • Average True Range (ATR)
  • PPBT 0.26
  • EVAX 1.10
  • MACD
  • PPBT -0.02
  • EVAX -0.02
  • Stochastic Oscillator
  • PPBT 27.24
  • EVAX 2.11

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

Share on Social Networks: